on 19 Jun 2024
Last Applicant/ Owned by
AMOLYT PHARMA
15 Chemin du Saquin,Espace Européen, Building GF-69130 Écully
FR
Serial Number
2333825 filed on 26th Apr 2024
Correspondent Address
BCF S.E.N.C.R.L./BCF LLP
1100, boul. René-Lévesque Ouest25e ÉtageMontréal
QUÉBEC
CA
H3B5C9
Trademark usage description
préparations pharmaceutiques pour le traitement de l'hypoparathyroïdie, y compris l'énéboparatide.12
2333825
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 256 on 21st Apr 2025 | Notification of Possible Opposition Sent |
Submitted for opposition 48 on 27th Jun 2024 | Agent Changed |
Submitted for opposition 257 on 20th Jun 2024 | Designation Notification - Madrid Protocol |
Submitted for opposition 1 on 19th Jun 2024 | Created |
Submitted for opposition 31 on 19th Jun 2024 | Formalized |
Submitted for opposition 30 on 26th Apr 2024 | Filed |
Submitted for opposition 228 on 26th Apr 2024 | International Registration |
This website uses cookies
Manage cookies
You can choose to enable or disable some or all of these cookies but disabling some of them may affect your browsing experience.
Advertisement
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously
Analytics
Analytical cookies are used to understand how visitors interact with the website.
Functional
Functional cookies help perform certain functionalities like collecting feedback, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website.